Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
85.04
+1.55 (1.86%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $6.94 billion as of March 9, 2026. Its market cap has increased by 186.48% in one year.
Market Cap
6.94B
Enterprise Value
5.41B
1-Year Change
186.48%
Ranking
Category
Stock Price
$85.04
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $6.94B, an increase of 732.00%. That is a compound annual growth rate of 46.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 8.50B |
| Axsome Therapeutics | 8.41B |
| Nuvalent | 8.04B |
| Halozyme Therapeutics | 8.04B |
| Cytokinetics | 7.69B |
| Krystal Biotech | 7.56B |
| Belite Bio | 7.05B |
| Arcellx | 6.70B |